Telemedycyna Polska SA
WSE:TMP
Gross Margin
Telemedycyna Polska SA
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | Company | Market Cap |
Gross Margin |
||
---|---|---|---|---|---|
PL |
T
|
Telemedycyna Polska SA
WSE:TMP
|
7.2m PLN |
48%
|
|
US |
![]() |
Cigna Corp
NYSE:CI
|
80B USD |
10%
|
|
US |
C
|
Cigna Group
XMUN:CGN
|
67.9B EUR |
10%
|
|
US |
![]() |
CVS Health Corp
NYSE:CVS
|
76.6B USD |
14%
|
|
DE |
![]() |
Fresenius Medical Care AG
XMUN:FME
|
26.5B EUR |
24%
|
|
DE |
![]() |
Fresenius SE & Co KGaA
XETRA:FRE
|
23.7B EUR |
24%
|
|
US |
![]() |
Laboratory Corporation of America Holdings
NYSE:LH
|
22.2B USD |
28%
|
|
US |
![]() |
Quest Diagnostics Inc
NYSE:DGX
|
18.9B USD |
33%
|
|
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
13.2B EUR |
24%
|
|
US |
![]() |
Hims & Hers Health Inc
NYSE:HIMS
|
12.9B USD |
77%
|
|
US |
![]() |
DaVita Inc
NYSE:DVA
|
11.2B USD |
32%
|
Telemedycyna Polska SA
Glance View
Telemedycyna Polska SA engages in the provision of medical treatment. The company is headquartered in Katowice, Woj. Slaskie. The company went IPO on 2010-08-18. The company operates Kardiotele system which enables cardiologic care and checks such as electrocardiogram (EKG) through telephone connection. Kariotele is addressed to individuals, as well as to nursing homes and rehabilitation centers. As of December 31, 2011, the Company operated one wholly owned subsidiary, Centrum Nadzoru Kardiologicznego Kardiofon Sp. z o.o.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Telemedycyna Polska SA's most recent financial statements, the company has Gross Margin of 48%.